Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Jarnicki

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Journal of Immunology (Baltimore, Md. : 1950)|May 29, 2020
CCL17 in Inflammation and PainKevin M-C Lee, Andrew Jarnicki, Adrian Achuthan, et al.
ERJ Open Research|March 9, 2023
Prime-boost, double-dose influenza vaccine immunity in COPD: a pilot observational studyGary P Anderson, Louis B Irving, Andrew Jarnicki, et al.
Cancer Research|February 4, 2016
Stomach-Specific Activation of Oncogenic KRAS and STAT3-Dependent Inflammation Cooperatively Promote Gastric Tumorigenesis in a Preclinical ModelStefan Thiem, Moritz F Eissmann, Joachim Elzer, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|November 2, 2022
Gastrointestinal consequences of lipopolysaccharide-induced lung inflammationRachel M McQuade, Methma Bandara, Shanti Diwakarla, et al.
ERJ Open Research|October 29, 2025
Priming mucosal pathogen-agnostic innate immunity with an intranasal TLR2/6 agonist in an aged populationFrancesca A Mercuri, Aowen Zhuang, Hayley A McQuilten, et al.
The Journal of Clinical Investigation|January 17, 2013
mTORC1 inhibition restricts inflammation-associated gastrointestinal tumorigenesis in miceStefan Thiem, Thomas P Pierce, Michelle Palmieri, et al.
Nature Communications|June 23, 2019
IL-33-mediated mast cell activation promotes gastric cancer through macrophage mobilizationMoritz F Eissmann, Christine Dijkstra, Andrew Jarnicki, et al.
Cancer Cell|August 17, 2013
Interleukin-11 is the dominant IL-6 family cytokine during gastrointestinal tumorigenesis and can be targeted therapeuticallyTracy L Putoczki, Stefan Thiem, Andrea Loving, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Journal of Immunology (Baltimore, Md. : 1950)|May 29, 2020
CCL17 in Inflammation and PainKevin M-C Lee, Andrew Jarnicki, Adrian Achuthan, et al.
ERJ Open Research|March 9, 2023
Prime-boost, double-dose influenza vaccine immunity in COPD: a pilot observational studyGary P Anderson, Louis B Irving, Andrew Jarnicki, et al.
Cancer Research|February 4, 2016
Stomach-Specific Activation of Oncogenic KRAS and STAT3-Dependent Inflammation Cooperatively Promote Gastric Tumorigenesis in a Preclinical ModelStefan Thiem, Moritz F Eissmann, Joachim Elzer, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|November 2, 2022
Gastrointestinal consequences of lipopolysaccharide-induced lung inflammationRachel M McQuade, Methma Bandara, Shanti Diwakarla, et al.
ERJ Open Research|October 29, 2025
Priming mucosal pathogen-agnostic innate immunity with an intranasal TLR2/6 agonist in an aged populationFrancesca A Mercuri, Aowen Zhuang, Hayley A McQuilten, et al.
The Journal of Clinical Investigation|January 17, 2013
mTORC1 inhibition restricts inflammation-associated gastrointestinal tumorigenesis in miceStefan Thiem, Thomas P Pierce, Michelle Palmieri, et al.
Nature Communications|June 23, 2019
IL-33-mediated mast cell activation promotes gastric cancer through macrophage mobilizationMoritz F Eissmann, Christine Dijkstra, Andrew Jarnicki, et al.
Cancer Cell|August 17, 2013
Interleukin-11 is the dominant IL-6 family cytokine during gastrointestinal tumorigenesis and can be targeted therapeuticallyTracy L Putoczki, Stefan Thiem, Andrea Loving, et al.
Pageof 2